Literature DB >> 22086858

Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

F Kate Gould1, David W Denning, Tom S J Elliott, Juliet Foweraker, John D Perry, Bernard D Prendergast, Jonathan A T Sandoe, Michael J Spry, Richard W Watkin.   

Abstract

The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in 2004. The guidelines presented here have been updated and extended to reflect developments in diagnostics, new trial data and the availability of new antibiotics. The aim of these guidelines, which cover both native valve and prosthetic valve endocarditis, is to standardize the initial investigation and treatment of IE. An extensive review of the literature using a number of different search criteria has been carried out and cited publications used to support any changes we have made to the existing guidelines. Publications referring to in vitro or animal models have only been cited if appropriate clinical data are not available. Randomized, controlled trials suitable for the development of evidenced-based guidelines in this area are still lacking and therefore a consensus approach has again been adopted for most recommendations; however, we have attempted to grade the evidence, where possible. The guidelines have also been extended by the inclusion of sections on clinical diagnosis, echocardiography and surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086858     DOI: 10.1093/jac/dkr450

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  111 in total

1.  Monomer complexes of polyadenylic acid.

Authors:  R Jeremy; H Davies
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

Review 2.  Current trends in the management of cardiac implantable electronic device (CIED) infections.

Authors:  Emanuele Durante-Mangoni; Irene Mattucci; Federica Agrusta; Marie-Françoise Tripodi; Riccardo Utili
Journal:  Intern Emerg Med       Date:  2012-06-29       Impact factor: 3.397

Review 3.  Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.

Authors:  Sebastiano Leone; Silvana Noviello; Silvano Esposito
Journal:  Infection       Date:  2015-09-01       Impact factor: 3.553

Review 4.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

5.  Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data.

Authors:  Achyut Guleri; Riccardo Utili; Pascal Dohmen; Kamal Hamed
Journal:  Ther Adv Infect Dis       Date:  2017-02-17

Review 6.  Infective endocarditis: therapeutic options and indications for surgery.

Authors:  Aneil Malhotra; Jenny Rayner; Timothy M Williams; Bernard Prendergast
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

7.  Community-acquired multidrug-resistant Gram-negative bacterial infective endocarditis.

Authors:  Sowjanya Naha; Kushal Naha; Vasudev Acharya; H Manjunath Hande; G Vivek
Journal:  BMJ Case Rep       Date:  2014-08-05

Review 8.  Surveillance of antibiotic resistance.

Authors:  Alan P Johnson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

Review 9.  Infective Endocarditis in the Elderly: Diagnostic and Treatment Options.

Authors:  M P Ursi; E Durante Mangoni; R Rajani; J Hancock; J B Chambers; B Prendergast
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

10.  The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin-resistant Staphylococcus aureus USA400 in Rio de Janeiro, Brazil.

Authors:  P V Damasco; F S Cavalcante; R C Chamon; D C Ferreira; S S Rioja; M V Potsch; M P Pastura; V D Marques; M B Castier; E A Marques; K R N Santos
Journal:  Infection       Date:  2013-03-02       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.